What is Progyny's cash & equivalents?

Progyny (PGNY) reported cash & equivalents of $131.61M in Q1 2026.

How has Progyny's cash & equivalents changed year-over-year?

Progyny's cash & equivalents increased by 20.5% year-over-year, from $109.24M to $131.61M.

What is the long-term trend for Progyny's cash & equivalents?

Over 5 years (2020 to 2025), Progyny's cash & equivalents has grown at a 9.8% compound annual growth rate (CAGR), from $70.31M to $112.24M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Progyny PGNY Cash & Equivalents

Cash & Equivalents at other companies

CVS HealthCVS

$9.77B-5.6%

UnitedHealth GroupUNH

$28B-8.8%

Natera, Inc.NTRA

$1.09B+11.7%

Pediatrix Medical GroupMD

$205.78M+108%

OrganonOGN

$1.12B+104%

BillionToOne, Inc. BLLN

$537.45M+181%

Other financials

Income statement

See full

Revenue$328.5M+1.4%

Gross profit$83.1M+9.6%

Operating income$35.4M+46.4%

Net income$24.2M+60.9%

EPS (diluted)$0.29+70.6%

Balance sheet

See full

Total debt$27.3M-5.6%

Total equity$439.3M-6.0%

Total assets$698.3M-4.4%

Cash flow

See full

Operating cash flow$45.9M-7.7%

CapEx$6.3M+123%

Free cash flow$39.6M-15.7%

Valuation

See full

Market cap$2.09B-27.1%

Enterprise value$1.98B-29.6%

P/E30.8×-23.7×

P/S1.6×-0.7×

Profitability

See full

Gross margin24.1%+2.1pp

Operating margin7.5%+1.4pp

Net margin5.2%+0.9pp

FCF margin14.3%-1.9pp

Returns & leverage

See full

Return on equity14.9%+4.8pp

Debt / equity0.1×0.0×

Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Progyny's cash & equivalents?: Progyny (PGNY) reported cash & equivalents of $131.61M in Q1 2026.
How has Progyny's cash & equivalents changed year-over-year?: Progyny's cash & equivalents increased by 20.5% year-over-year, from $109.24M to $131.61M.
What is the long-term trend for Progyny's cash & equivalents?: Over 5 years (2020 to 2025), Progyny's cash & equivalents has grown at a 9.8% compound annual growth rate (CAGR), from $70.31M to $112.24M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.